Covid-19 has exposed the limits of today's drug development model - STAT

Covid-19 has exposed the limits of today's drug development model - STAT

Covid-19 has exposed the limits of the pharmaceutical market model

By TAHIR AMIN AND ROHIT MALPANI

ADOBE

Remdesivir is the poster child for why we need a new model of drug development for pandemics and neglected diseases that isn't market-based.

READ MORE